相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients
Giulia Rastrelli et al.
ANDROLOGY (2021)
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection
Jin Wei et al.
CELL (2021)
Associations Between Genetically Predicted Protein Levels and COVID-19 Severity
Jingjing Zhu et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients
J. Mccoy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
The Impact of COVID-19 Disease on Platelets and Coagulation
Geoffrey D. Wool et al.
PATHOBIOLOGY (2021)
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
Hannes Vietzen et al.
GENETICS IN MEDICINE (2021)
Genetic mechanisms of critical illness in COVID-19
Erola Pairo-Castineira et al.
NATURE (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Genetic and epigenetic factors associated with increased severity of Covid-19
Zafer Yildirim et al.
CELL BIOLOGY INTERNATIONAL (2021)
Role of Toll-like receptors in the pathogenesis of COVID-19
Shaghayegh Khanmohammadi et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
Sirui Zhou et al.
NATURE MEDICINE (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A genomic region associated with protection against severe COVID-19 is inherited from Neandertals
Hugo Zeberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
Fei Li et al.
NATURE COMMUNICATIONS (2021)
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study
Chiara Fallerini et al.
ELIFE (2021)
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
Margherita Baldassarri et al.
EBIOMEDICINE (2021)
Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19
Qu Deng et al.
ISCIENCE (2021)
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei et al.
CIRCULATION RESEARCH (2021)
The MUC5B Promoter Polymorphism Associates With Severe COVID-19 in the European Population
Coline H. M. van Moorsel et al.
FRONTIERS IN MEDICINE (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity
Janie F. Shelton et al.
NATURE GENETICS (2021)
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Liam Gaziano et al.
NATURE MEDICINE (2021)
An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility
Liuyang Wang et al.
GENOME MEDICINE (2021)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan et al.
LANCET RESPIRATORY MEDICINE (2021)
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19
Immacolata Andolfo et al.
ISCIENCE (2021)
Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs
Sebastien Boutin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors
Jaroslav A. Hubacek et al.
CLINICA CHIMICA ACTA (2021)
Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation
Yulin Dai et al.
HUMAN GENETICS (2021)
Variants in ACE2; potential influences on virus infection and COVID-19 severity
Behnaz Bakhshandeh et al.
INFECTION GENETICS AND EVOLUTION (2021)
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
Victoria Callahan et al.
VIRUSES-BASEL (2021)
Androgen regulation of pulmonary AR, TMPRSS2 and ACE2 with implications for sex-discordant COVID-19 outcomes
Mehdi Baratchian et al.
SCIENTIFIC REPORTS (2021)
CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
Razie Amraei et al.
ACS CENTRAL SCIENCE (2021)
Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan
Yasuhiro Yamada et al.
EMERGING INFECTIOUS DISEASES (2021)
Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19
Gundula Povysil et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Genetic risk for severe COVID-19 correlates with lower inflammatory marker levels in a SARS-CoV-2-negative cohort
Timothy R. Powell et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
Gillian S. Dite et al.
EPIDEMIOLOGY AND INFECTION (2021)
Genome and epigenome editing identify CCR9 and SLC6A20 as target genes at the 3p21.31 locus associated with severe COVID-19
Yao Yao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis
Wanvisa Udomsinprasert et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
The COVID-19 epidemic
Thirumalaisamy P. Velavan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
Claire L. Niedzwiedz et al.
BMC MEDICINE (2020)
COVID-19 and ABO blood group: another viewpoint
Christiane Gerard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
Hin Chu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
Xiaofeng Dai
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Austin Nguyen et al.
JOURNAL OF VIROLOGY (2020)
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Jason Phua et al.
LANCET RESPIRATORY MEDICINE (2020)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1-30, 2020
Shikha Garg et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19)
Wei Wang et al.
HLA (2020)
Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes
Monojit Debnath et al.
FASEB JOURNAL (2020)
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
Nan Wang et al.
CELL HOST & MICROBE (2020)
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
Zulvikar Syambani Ulhaq et al.
MEDICINA CLINICA (2020)
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
David Ellinghaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19 a prospective observational study
Pratik Sinha et al.
LANCET RESPIRATORY MEDICINE (2020)
SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients
Juan Bizzotto et al.
ISCIENCE (2020)
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
Juan Gomez et al.
GENE (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
Philip A. Mudd et al.
SCIENCE ADVANCES (2020)
Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
Fang Wang et al.
CELL DISCOVERY (2020)
CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways
Alexander N. Wein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: a case-control study and a review of knowledge
Raheleh Assari et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Origin and development of oligoadenylate synthetase immune system
Jiaxiang Hu et al.
BMC EVOLUTIONARY BIOLOGY (2018)
Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding
Franklin L. Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Genome-wide association study of subclinical interstitial lung disease in MESA
Ani Manichaikul et al.
RESPIRATORY RESEARCH (2017)
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity
Calliope A. Dendrou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis
Hui Zhang et al.
FEBS JOURNAL (2015)
TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits
Dorothee Diogo et al.
PLOS ONE (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Raphael N. Vuille-dit-Bille et al.
AMINO ACIDS (2015)
The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis
Inga Patarcic et al.
SCIENTIFIC REPORTS (2015)
Foxp1/4 control epithelial cell fate during lung development and regeneration through regulation of anterior gradient 2
Shanru Li et al.
DEVELOPMENT (2012)
Foxp4 Is Dispensable for T Cell Development, but Required for Robust Recall Responses
Karla R. Wiehagen et al.
PLOS ONE (2012)
Association between CD209-336A/G and-871A/G Polymorphisms and Susceptibility of Tuberculosis: A Meta-Analysis
Kai Chang et al.
PLOS ONE (2012)
CD209 (DC-SIGN)-336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese
Kelvin Yuen Kwong Chan et al.
HUMAN IMMUNOLOGY (2010)
Significance of the Myxovirus Resistance A (MxA) Gene-123C>A Single-Nucleotide Polymorphism in Suppressed Interferon β Induction of Severe Acute Respiratory Syndrome Coronavirus Infection
Johannes Chi-Yun Ching et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The Type I Interferon Signaling Pathway Is a Target for Glucocorticoid Inhibition
Jamie R. Flammer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides
Ruth Geiss-Friedlander et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glucocorticoids inhibit IRF3 phosphorylation in response to toll-like receptor-3 and-4 by targeting TBK1 activation
Claire E. McCoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study
Jing He et al.
BMC INFECTIOUS DISEASES (2006)
DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells
Pierre-Emmanuel Ceccaldi et al.
JOURNAL OF VIROLOGY (2006)
Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population
E Hamano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
ACE1 polymorphism and progression of SARS
S Itoyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)